Latest revenue
$613.8M
as of 2026-03-31
Latest net income
$-63.8M
as of 2026-03-31
Net margin
-10.4%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $1.19B
- Enterprise value
- $1.19B
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $9.77
- 52-wk low
- $4.40
- Beta
- —
- Shares out
- 180.5M
5-year trend
What this company does
Item 1. Business Overview Teladoc Health is the global leader in virtual care. More than 20 years ago, we were founded on a simple, yet revolutionary idea: that everyone should have access to the best healthcare, anywhere in the world on their terms. Our mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. Today, we are transforming virtual care into a catalyst for how better health happens around the world. We connect patients, care providers, healthcare platforms and partners to provide more complete and personalized care. Through our unique technology, breadth of services and depth of clinical expertise, we are delivering…
AI summary unavailable — showing raw filing excerpt
Generated from TDOC's filing dated 2026-02-26
Key risks
Item 1A. Risk Factors Our business, financial and operating results are subject to many significant risks and uncertainties, as described below. The following is a summary of the material risks known to us. Additional risks and uncertainties that we are unaware of, or that we currently believe are not material, may also become important factors that adversely affect our business, financial condition, results of operations or prospects, and could cause the trading price of our common stock to decline. Risk Factors Summary Our business is subject to a number of risks and uncertainties, including those risks discussed at-length below. These risks include, among others, the following: •our…
AI summary unavailable — showing raw filing excerpt
Generated from TDOC's filing dated 2026-02-26
Profitability
Operating margin
-10.4%
73.8%Net margin
-7.9%
79.7%Return on equity
-13.4%
80.0%Return on assets
-7.0%
75.4%Leverage
Debt / equity
0.92×
32.5%Debt / assets
47.8%
17.0%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $613.8M | -2.5% | $-63.8M | +31.4% | -10.4% |
Q4 2025 2025-12-31 | $642.3M | +0.3% | $-25.1M | +48.1% | -3.9% |
Q3 2025 2025-09-30 | $626.4M | -2.2% | $-49.5M | -48.8% | -7.9% |
Q2 2025 2025-06-30 | $631.9M | -1.6% | $-32.7M | +96.1% | -5.2% |
Q1 2025 2025-03-31 | $629.4M | -2.6% | $-93.0M | -13.6% | -14.8% |
Q4 2024 2024-12-31 | $640.5M | — | $-48.4M | — | -7.6% |
Q3 2024 2024-09-30 | $640.5M | -3.0% | $-33.3M | +41.7% | -5.2% |
Q2 2024 2024-06-30 | $642.4M | -1.5% | $-837.7M | -1185.2% | -130.4% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Services-Offices & Clinics of Doctors of Medicine · SIC 8011
Your notes
Keep private notes on TDOC — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$69.4K
Insider selling
$1.9M
Net activity
−$1.9M
Distinct insiders
8
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns TDOC
Institutional value
$391.9M
Total shares held
73.7M
Distinct holders
197
-144 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 14.6M | $79.6M | +353.3K (+2.5%) | Added |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 12.3M | $67.0M | — | New |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 7.9M | $42.8M | — | New |
| 4 | DIMENSIONAL FUND ADVISORS LP | 6.3M | $34.3M | -1.2M (-16.0%) | Trimmed |
| 5 | Allianz Asset Management GmbH | 4.8M | $26.1M | +1.7M (+53.8%) | Added |
| 6 | Monaco Asset Management SAM | 4.0M | $22.0M | +2.1M (+105.9%) | Added |
| 7 | JUPITER ASSET MANAGEMENT LTD | 3.1M | $16.9M | -750.4K (-19.4%) | Trimmed |
| 8 | UBS Group AG | 1.7M | $9.4M | +228.3K (+15.2%) | Added |
| 9 | FEDERATED HERMES, INC. | 1.7M | $9.3M | +1.3M (+371.0%) | Added |
| 10 | BNP PARIBAS FINANCIAL MARKETS | 1.4M | $7.9M | -107.9K (-6.9%) | Trimmed |
| 11 | OP Asset Management Ltd | 1.3M | $7.5M | +1.3M (+10461.1%) | Added |
| 12 | VANGUARD FIDUCIARY TRUST CO | 1.2M | $6.4M | — | New |
| 13 | PRINCIPAL FINANCIAL GROUP INC | 718.7K | $3.9M | +130.6K (+22.2%) | Added |
| 14 | FRANKLIN RESOURCES INC | 627.4K | $3.4M | +160.9K (+34.5%) | Added |
| 15 | Bank of New York Mellon Corp | 604.6K | $3.3M | -16.7K (-2.7%) | Trimmed |
| 16 | Nuveen, LLC | 524.0K | $2.9M | -2.1M (-80.3%) | Trimmed |
| 17 | JPMORGAN CHASE & CO | 539.9K | $2.8M | -77.9K (-12.6%) | Trimmed |
| 18 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 481.3K | $2.6M | +68.4K (+16.6%) | Added |
| 19 | Universal- Beteiligungs- und Servicegesellschaft mbH | 407.3K | $2.2M | +34.0K (+9.1%) | Added |
| 20 | Voya Investment Management LLC | 377.1K | $2.1M | -13.3K (-3.4%) | Trimmed |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once TDOC's latest filing finishes processing.